Skip to Main Content

Paper Details

miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia.
Nat Commun
106
2016
AML, CREB, CRTC1, EZH2, FLT3, GFI1, MDS, MYC, MYCBP, MicroRNAs, SIN3A, TET1, acute myeloid leukaemia, breast cancer, leukaemia, leukaemic, leukaemic cell, miR, miR-, miR-22, myelodysplastic syndrome, oncogenes, tumour
Author NameAffiliation
Miao YuDepartment of Chemistry and Institute for Biophysical Dynamics, Howard Hughes Medical Institute, University of Chicago
Hao HuangUniversity of Chicago
Shenglai LiUniversity of Chicago
Abdel G ElkahlounNational Human Genome Research Institute
Zejuan LiUniversity of Chicago
Zejuan LiUniversity of Chicago
Chuan HeDepartment of Chemistry and Institute for Biophysical Dynamics, Howard Hughes Medical Institute, University of Chicago
Chuan HeDepartment of Chemistry and Institute for Biophysical Dynamics, Howard Hughes Medical Institute, University of Chicago
  • 1 - 8

Datasets

Release 1.2